Specifically, in vivo silencing of PRPF8 by siPRPF8 in established s.c. tumors significantly reduced tumor growth (Fig. 4b) and the final tumor weight (Fig. 4c) compared to those of scramble-treated tumors. This evidence concerns the gene PRPF8 and neoplasm.